TET2 and angioimmunoblastic T-cell lymphoma: G17V RhoA mutation has been studied extensively in the AITL, where generally arises in a permissive genetic background in which loss of function of Tet2 has occurred as first hit of lymphomagenesis suggesting a cooperative role of these alterations in the pathogenesis of AITL (45).